Female Genital Schistosomiasis Can Reduce Women’s HIV Risk

In this particular Huffington Post "Global Motherhood" article, Peter Hotez, president of a typical Sabin Vaccine Institute and dean of the National School of Tropical Medicine at Baylor College of Medicine, explains female genital schistosomiasis (FGS), which generally impacts above 100 million women and girls in the african continent and "causes horrifying pain and bleeding in the uterus, cervix and lower genital tract, in addition to social stigma and melancholy.

Hotez says Merck Serono has donated 250 million of a typical eight-cent praziquantel tablets, and personal donors, USAID, and the British Department for International Development (DfID) "have set out to support methods of praziquantel mass therapy for schistosomiasis influence." He includes that he has "argued that in fact large-scale AIDS treatment programs for example the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) must also adopt annual praziquantel therapies.